2Pincus T.Aggressive treatment of early rheumatoid arthritis to prevent joint damage[J].Bull Rheum Dis,1998,47(1):2 -7.
3Schellekens GA,De Jong BA,Van Den Hoogen FHJ,et al.Citrulline is an essential constituent of antigenic determinants recognized by rhrumatoid arthritis-specific autoantibodies[J].J Clin Invest,1998,101:273-281.
4Schellekens GA,Visser H,De Jong BA,et al.The diagnostic properties of rheumatoid arthritis recognizing a cyclic citrullinated peptide[J].Arthritis Rheum,2000,43:155-163.
5Raza K,Breese M,Nightingale P,et al.Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis[J].J Rheumatol,2005,32:231-238.
6Tampoia M,Brescia V,Fontana A,et al.Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay:Analytical performance and clinical correlations[J].Clin Chim Acta,2005,355:137-144.
7Gabriel SE. The epidemiology of rheumatoid arthritis [ J ]. Rheum Dis Clin North Am,2001,27 (2) :269-281.
8ScheUekens GA, Visser H, DeJong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide [ J ]. Ar- thritis Rheum, 2000, 43 (1) : 155 - 163.
9Schellekens GA,de Jong BAW,van den Hoogen FH,et al.Citruline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies[J].J Immunol,2015,195(1):8-16.
10Schellekens GA,Visser H,de Jong BA,et al.The diagnostic propErtiesof rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide[J].Arthritis Rheum,2000,43(1):155-163.
